Resolutions at the Extraordinary General Meeting in Biotage AB on November 21, 2008

At the Extraordinary General Meeting held in Biotage AB (Reg. No. 556539-3138) on November 21, 2008, the following resolution was passed.

Resolution on reduction of statutory reserve
The General Meeting resolved to reduce the company’s statutory reserve with an amount of SEK 842.180.000 by means of transfer of the aforesaid amount to a reserve to be used in accordance with resolution/s adopted at forthcoming General Meetings.

The statutory reserve will be entirely dissolved following the execution of the said reduction. Approval by the Swedish Companies Registration Office (Sw. Bolagsverket), or the general court (Sw. allmän domstol) in case of a dispute, is required to effectuate the proposed reduction of statutory reserve.


Uppsala, November 21, 2008
Biotage AB (publ)
The Board of Directors

Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84,  

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT  

Related documents

 
 
 
 
Social Media Pitch:
Resolutions at the Extraordinary General Meeting in Biotage AB on November 21, 2008